Misato Higasa

Misato Higasa

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Respiratory Investigation
Verified
Journal Article
Open access
MHMegumi Hamaguchi
Megumi Hamaguchi
YTYukari Tsubata
Yukari Tsubata
ATAkari Tanino
Akari Tanino
YMYuki Mitarai
Yuki Mitarai
KHKojiro Hata
Kojiro Hata
TITakeshi Isobe
Takeshi Isobe
Some randomized controlled trials have evaluated the effects of low-dose computed tomography (CT) screening on lung cancer mortality in heavy smokers. Based on the results of those trials, our CT screening program recommended screening for people aged ≥40 years with a history of smoking. This retrospective study aimed to verify the validity of our CT screening program and elucidate the current state of CT screening program. We retrospectively examined lung cancer detection in 25,189 participants who underwent chest CT screening by a mobile low-dose CT screening unit in the 10-year period from April 2009 to March 2019. Participants were recruited at Japan Agricultural Cooperatives (JA) Shimane Kouseiren. Participants requested CT screening for lung cancer. CT images were read by two pulmonologists. Lung cancer was identified in 82 of the 25,189 participants over 10 years, an overall lung cancer detection rate (percentage of lung cancers detected among all participants) of 0.33%. Lung cancer among never smokers accounted for 54.9% of the detected cases. The lung cancer detection rate was similar for smokers versus never smokers. The stage IA detection rate (percentage of stage IA lung cancers among all lung cancers detected) was 62%, while the stage Ⅳ detection rate was 10%. Chest CT detected lung cancer in never smokers as well as current or former smokers. Our CT screening program was not effective for never smokers; thus, further study of the effectiveness of CT screening in never smokers is needed.

22 February 2022 in Respirology Case Reports
Verified
Journal Article
Open access
MHMisato Higasa
Misato Higasa
YTYukari Tsubata
Yukari Tsubata
YSYohei Shiratsuki
Yohei Shiratsuki
THTakamasa Hotta
Takamasa Hotta
MHMegumi Hamaguchi
Megumi Hamaguchi
TITakeshi Isobe
Takeshi Isobe
A 69‐year‐old woman with rheumatoid arthritis, using immunosuppressants, including etanercept—a tumour necrosis factor (TNF)‐α antagonist—was referred to our hospital with fever and fatigue. Chest computed tomography revealed cavities in the left upper lobe. As Mycobacterium intracellulare infection was diagnosed, all immunosuppressants were discontinued, and treatment with anti‐nontuberculous Mycobacterium drugs was initiated. However, her condition worsened paradoxically. We diagnosed immune reconstitution inflammatory syndrome (IRIS) resulting from the discontinuation of the TNF‐α antagonist. Her condition improved with prednisolone treatment. IRIS is generally observed during HIV treatment, but a good understanding of immunosuppressant‐related non‐HIV IRIS is needed.

30 March 2022 in Case Reports in Oncology
Verified
Journal Article
Open access
PDF file
KKKeita Kawakado
Keita Kawakado
THTakamasa Hotta
Takamasa Hotta
JSJin Sakamoto
Jin Sakamoto
MHMika Horie
Mika Horie
MHMisato Higasa
Misato Higasa
TITakeshi Isobe
Takeshi Isobe
The patient, a 62-year-old woman, complained chiefly of cough. We planned chemoradiotherapy for squamous nonsmall cell lung cancer. A single dose of 2-Gy irradiation and no anticancer agent administration exacerbated the airway stenosis with severe respiratory failure. Urgent tracheal intubation was performed, and a tracheal stent was implanted under extracorporeal membrane oxygenation (ECMO). Because her performance status (PS) worsened from 1 to 2, we administered radiotherapy. The tumor size decreased. There was no recurrence for the next 3 months, and her PS improved to 1. Emergency tracheal intubation and tracheal stent placement under ECMO can be effective for exacerbated airway obstruction after radiotherapy.

28 November 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MNMika Nakao
Mika Nakao
TOTamio Okimoto
Tamio Okimoto
NKNoriaki Kurimoto
Noriaki Kurimoto
RTRyosuke Tanino
Ryosuke Tanino
MHMisato Higasa
Misato Higasa
TITakeshi Isobe
Takeshi Isobe
Background: During bronchial lavage, the lumen can be viewed better by injecting physiological saline into the bronchus. This study aimed to investigate the effect of injecting physiological saline into the bronchus while directly observing the bronchial lumen with peripheral pulmonary lesions using an ultrathin bronchoscope. Methods: We evaluated changes in the depth of field and signal-to-noise ratio due to saline immersion in bronchoscopic images captured with line patterns. We injected physiological saline through the working channel into the bronchial lumen and directly observed the lesions (mainly in cases of suspected peripheral lung cancer) in 38 patients using white-light and narrow-band imaging. Ultrathin bronchoscopic findings and histopathological diagnoses were analyzed. Results: Saline immersion extended the range of subject distance within the depth of the field with an improved signal-to-noise ratio. Saline immersion elevated the signal-to-noise ratio and increased the highest signal-to-noise ratio in the white-light images from 3.12 dB to 3.77 dB (1.21-fold). Under narrow-band imaging, saline immersion also increased the highest signal-to-noise ratio from 5.18 dB to 6.44 dB (1.24-fold). We were able to directly observe the bronchial lumen of the peripheral lesions in 30/38 cases (78.9%). Three (60%) of the five squamous cell carcinomas were of the epithelial type, and 12 (92%) of the 13 adenocarcinomas, including peripheral pulmonary lesions, were of the subepithelial type, similar to central lesions. Conclusions: Injecting saline into the peripheral bronchus is useful for direct bronchoscopic evaluation of peripheral lesions.

26 June 2022 in Respirology Case Reports
Verified
Journal Article
Open access
MHMisato Higasa
Misato Higasa
NKNoriaki Kurimoto
Noriaki Kurimoto
YMYuki Mitarai
Yuki Mitarai
TOTakae Okuno
Takae Okuno
MNMika Nakao
Mika Nakao
TITakeshi Isobe
Takeshi Isobe
A light blue line (LBL) was observed along the edge of a lesion using narrow band imaging under saline injection during bronchoscopy in an 82‐year‐old patient with a lobulated mass on the left B4. The histopathological diagnosis was hamartoma with ciliated bronchial epithelium, and we speculated that LBL appeared around the ciliated bronchial epithelium.